News
All News
Publications
All PublicationsPharmTechPharmTech Europe
Multimedia
All VideosAsk the ExpertBehind The HeadlinesDrug Digest VideosDrug Solutions Podcast
Conferences
Conference CoverageConference Listing
More
Webcasts
Resources
ICH Q9 Revision: A Comprehensive Resource on Quality Risk ManagementPartnersPeer-Reviewed ResearchPharmTech ProductsPharma InsightsSponsored PodcastsSponsored VideosSponsored eBooksState of the ScienceWhitepapers

Subscribe

  • News
  • Publications
  • Multimedia
  • Conferences
  • Webcasts
  • Resources
  • Subscribe
  • Analytics
    • Bio/Pharmaceutical Analysis Techniques
    • Laboratory Equipment and Instruments
  • Data and Artificial Intelligence
  • Dosage Forms
    • Solid/Semi-Solid Dosage
    • Specialty Dosage Drugs
    • Parenterals and Injectables
    • Inhalation Drugs
  • Drug Development
    • Intellectual Property and Patents
    • Process and Scaling
    • APIs and Excipients
    • Ingredients
    • Formulation and Drug Delivery
  • Manufacturing
    • Aseptic/Sterile Processing
    • Equipment
    • Process and Automation
    • Manufacturing, Parenterals and Injectables
    • Manufacturing, Biosimilars and Biobetters
    • Manufacturing, Inhalation Drugs
    • Manufacturing, Solid and Semi-Solid Dosage Drugs
    • Manufacturing, Cell Therapies
    • Manufacturing, Biologic Drugs
    • Supply Chain
    • Manufacturing, Gene Therapies
    • Packaging and Distribution
  • Outsourcing
    • Contract Research Services
    • Contract Analytical Services
    • Contract Development Services
    • Regulatory Consulting
    • Logistics and Distribution
    • Contract Manufacturing Services
  • Quality Systems
    • Ask the Expert
    • Quality Assurance/Quality Control
    • Regulatory Oversight and Compliance
Spotlight -
Analytics|
Dosage Forms|
Drug Development|
Manufacturing|
Outsourcing|
Quality Systems
Advertisement
News|Articles|January 2, 2018

Risk Assessments and Sourcing Strategies for Excipients and APIs

Author(s)USP
Advertisement
External Link - PT1217 USP-Andruski F&C pr1f2-Web.pdf

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Subscribe Now!
Advertisement

Related Content

Advertisement
Concept of EMA European Medicines Agency. Drugs evaluation and quality control department. | Image Credit: ©wladimir1804 -stock.adobe.com

EMA Director Sees Legislation Revamp as Highlight of 2025

BySusan Haigney
December 19th 2025
Sustainability FAQ

FAQ: Sustainability in Pharma

ByChristopher Cole
December 19th 2025
Dr. Eva-Maria Hempe, NVIDIA

Momentum and Automation Driving Pharma Innovation and Digitalization Through 2026

ByChristopher Cole
December 18th 2025

Ask the Expert: Training for a Skilled Workforce

BySusan J. Schniepp,Siegfried Schmitt,Susan Haigney
December 18th 2025
AI generative concept with businessman pointing on artificial intelligence to create prompt for command and generate ai to get output such as picture, music and video or data analysis | Image Credit: © AREE - stock.adobe.com

Accelerating HTA Readiness with Generative AI

ByAngeline Dhas
December 17th 2025
Advertisement
Advertisement

Trending on Pharmaceutical Technology

1

CNPV Deep Dive: Perspectives on Accelerated FDA Review From the C-Suite to the Manufacturing Floor

2

Multi-Compendial Compliance for Pharmaceutical Excipients–Part 1: A Practical Application of Specification Equivalence

3

De-risking Biologic Development: Engineering Flexibility from Early Development to Launch

4

Behind the Headlines Episode 30: 2026 Wish List

5

Momentum and Automation Driving Pharma Innovation and Digitalization Through 2026

  • About Us
  • Advertise
  • Contact Us
  • Editorial Info
  • Editorial Advisory Board
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us